Close Menu

NEW YORK – Proteomics firm Somalogic is exploring quantum biosensing technology under a $1 million grant from the National Science Foundation's Convergence Accelerator program.

The effort, which involves collaborators at the University of Chicago, University of California, Los Angeles, University of California, Santa Barbara, and University of Washington could allow the company to explore more portable applications of its SomaScan technology while also potentially improving the specificity of its proteomic measurements, said Jason Cleveland, principal fellow at Somalogic.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.